Filter posts

#BIOCEO18: A Bright Future

“A transformative year in medicine.” That’s how BIO President and CEO Jim Greenwood recently described …

Here We Go Again (But In a Good Way)

“We achieved the lowest drug trend since we began measuring drug trend data in 1993.” …

Cancer Surpasses Malaria as Top Public Health Threat in Africa

Africa is known for its diverse cultures, expansive landscapes, dramatic coastlines, luscious forests and exotic …

Drug Discount Program Strays from Patient Health to Hospital Wealth

It’s been 25 years since Congress created the 340B Drug Discount Program, a program designed …

For Health Insurers, Business is Booming. But at Whose Expense?

Good news for the health insurance industry: business is booming – insurer stock prices soared …

Biopharma Steps Up as Diabetes Epidemic Goes Global

This May, the World Health Organization (WHO) named its new Director-General Dr. Tedros Adhanom Chebreyesus, …

What's Driving Health Care Spending? Hint: Not Drug Costs.

With health care costs an important concern for many Americans, a common misperception is the …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

#BIO2017 Fireside Chat: Unlocking the Power of the Genome

To Francis deSouza, genomics is a transformational force. deSouza, President and CEO of Illumina, joined …

8 Reasons New Medicines are Needed for Alzheimer’s

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel …